Day One Biopharmaceuticals (DAWN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist

13.720
+0.380+2.85%

Close Nov 22 16:00 ET

13.980
+0.260+1.90%

Post 20:01 ET

1.38BMarket Cap-14144P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Day One Biopharmaceuticals Announces Leadership Transition
TipRanksNov 20 16:56 ET
Express News | Day One Announces Retirement of DR. Samuel Blackman, Co-Founder and Head of Research & Development
ReutersNov 20 16:30 ET
JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas
Seeking AlphaNov 19 11:06 ET
Day One Biopharmaceuticals Insider Sold Shares Worth $456,223, According to a Recent SEC Filing
MT NewswiresNov 12 17:04 ET
Day One Biopharmaceuticals Management to Meet With Piper Sandler
TipRanksNov 11 07:50 ET
Express News | Day One Biopharmaceuticals Inc : JP Morgan Raises Target Price to $39 From $36
ReutersNov 7 00:04 ET

Comments

IDKWTFIMDOING

Jul 25 13:43

$Day One Biopharmaceuticals (DAWN.US)$
https://www.tipranks.com/news/blurbs/strong-buy-rating-for-day-one-biopharmaceuticals-amid-strategic-partnership-and-promising-financial-health?futusource=news_stock_stockpagenews&ns_stock_id=80620831336770&src=2&utm_medium=referral&utm_source=moomoo.com&client_hour_clock=24&clientlang=2

Trytosaveabit

Jul 25 02:47

$Day One Biopharmaceuticals (DAWN.US)$ Ipsen And Day One Enter Ex-U.S. Licensing Deal For Pediatric Brain Cancer Drug Tovorafenib
Benzinga· 01:54
Ipsen secures ex-U.S. regulatory and commercial rights to tovorafenib for most common childhood brain tumor, pediatric low-grade glioma (pLGG), and any future indications
OJEMDA (tovorafenib) is the first FDA-approved treatment for relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or V600 mutation, following the pivotal Phase II tria...

MARKET-TEST-DUMMY

Jun 19 15:39

turn around

$Day One Biopharmaceuticals (DAWN.US)$ we gonna see retraisement back to 18?

Trytosaveabit

Jun 12 06:34

Update

$XOMA Corp (XOMA.US)$ $Day One Biopharmaceuticals (DAWN.US)$ XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of Its Priority Review Voucher